Limited Time Events
- This event has passed.
Finding Balance in the Treatment of Bipolar 1 Disorder and Schizophrenia
December 6, 2022 @ 6:30 pm – 8:30 pm UTC-7
About the Program
Despite a wealth of antipsychotic treatment options in Canada, many important gaps persist in the management of both bipolar I disorder (BPI) and schizophrenia (SZ).
Please join your peers for an informative and interactive session focusing on the addition of a new agent to the antipsychotic armamentarium.
Speaker
Karen Parker, NP Adult, PM-NP, A-GNP, MSc, BN
At the conclusion of the session, participants will be able to:
Identify current unmet needs for patients with Bipolar 1 Disorder
◊ Explain similarities, differences, and potential clinical implications of cariprazine’s pharmacologic characteristics relative to previously approved 2nd and 3rd-generation antipsychotics.
◊ Describe the efficacy and safety of cariprazine in clinical trials in Bipolar 1 Disorder
◊ Define the place of cariprazine in clinical practice among patients with Bipolar 1 Disorder
RSVP to
Jamie Shewchuk
jame.shewchuk@abbvie.com
403-561-0322
Location
Osteria De Medici – Kensington
201 – 10 St NW
Calgary, AB